PAREXEL ANNOUNCES INVESTOR DAY WEBCAST ON JUNE 7
BOSTON, MA, May 30, 2007 – PAREXEL International Corporation (NASDAQ: PRXL) today announced that it will be webcasting its Investor Day on Thursday, June 7, from 8:30 a.m. to 12:30 p.m. ET. All interested parties are invited to listen as Chairman and CEO Josef H. von Rickenbach and other members of the executive team provide a strategic overview of the Company’s businesses and markets through a series of presentations, followed by a question and answer session.
Those who wish to listen to the Investor Day presentations and view the accompanying slides should log onto the investor relations section of the Company’s website at www.PAREXEL.com and click on “Webcasts,” prior to the event’s start at 8:30 a.m. ET. In addition, an archived version of the event’s presentations will be available on PAREXEL’s website in the Investor Relations section.
About PAREXEL International
PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 55 locations throughout 43 countries around the world, and has over 6,315 employees. For more information about PAREXEL International visit www.PAREXEL.com.